Treatment of influenza A (H1N1) virus infection with ribavirin aerosol
- PMID: 6486761
- PMCID: PMC284119
- DOI: 10.1128/AAC.26.2.200
Treatment of influenza A (H1N1) virus infection with ribavirin aerosol
Abstract
In a randomized, controlled study of ribavirin aerosol treatment of influenza A(H1N1) virus infection among college students, treated patients had a significantly shorter duration of fever than control patients. There was a trend of more rapid recovery in treated patients. Virus shedding was similar in treated and control patients, declining gradually from a 50% tissue culture infective dose of 3.5 log10 per ml at admission to 1.8 log10 per ml at 53 h after admission. There was no local or systemic intolerance and no hematological or biochemical abnormalities associated with ribavirin treatment.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
